Phase III Study (SATURN) Showed Tarceva Improved Progression-Free Survival As A First-Line Maintenance Therapy For Advanced Non-Small Cell Lung Cancer

Genentech, Inc., (NYSE: DNA) and OSI Pharmaceuticals, Inc.

Related Posts

  1. Significant Free Knowledgebase Pertaining To Where To Purchase Oticon Bte Digital Hearing Aids
  2. December Issue Of Cell Features NIDA-Funded Study That Focuses On The Generation Of Stem Cell Lines In Rats

Tags: , ,

This entry was posted on Sunday, November 9th, 2008 at 2:00 pm and is filed under Hearing Aids. You can follow any responses to this entry through the RSS 2.0 feed. Responses are currently closed, but you can trackback from your own site.

« Contour® From Bayer Provides Reliable And Intuitive Blood Glucose Monitoring
Significant Free Knowledgebase Pertaining To Where To Purchase Oticon Bte Digital Hearing Aids »

Comments are closed.